Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial.
about
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisLong-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.Strategies to improve adherence and outcomes in patients with ulcerative colitis.Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis.Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis.New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.MMX mesalamine is safe and efficacious in achieving clinical and endoscopic remission of active ulcerative colitis.Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.
P2860
Q24185774-074F3994-A57E-4F3E-A3D5-2B52352588D1Q24198786-8A5811E4-1F87-43BC-B8CA-D6AFCE68ADFFQ34273329-08016DB8-9FA0-452A-8019-148B3D3BEF3AQ37354123-2D4C6FD1-77D1-400E-85C8-E085156B3159Q37926915-77862727-C54A-4B80-9F46-8F1B58D05B27Q37995669-AC659A42-F2E4-4B63-A921-15EF7FD9C936Q38014364-9E7165FC-862A-4EC8-A20C-89B849B6B60EQ38625992-5DEB7094-F1B2-46A6-9DB7-EA0A86210BF5Q38841927-3494FAC7-7CBC-4B04-8ECE-12D0E099A378Q42874557-D591A0AE-C1D5-4D6C-8658-D6BA83A58F18Q42877648-CADDE281-249F-4F16-A1B0-377DC2F9CCC1Q48346132-9A9004FE-B122-4F18-803C-35CFBE29C2D6
P2860
Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Once daily versus conventional ...... sults from a randomized trial.
@en
Once daily versus conventional ...... sults from a randomized trial.
@nl
type
label
Once daily versus conventional ...... sults from a randomized trial.
@en
Once daily versus conventional ...... sults from a randomized trial.
@nl
prefLabel
Once daily versus conventional ...... sults from a randomized trial.
@en
Once daily versus conventional ...... sults from a randomized trial.
@nl
P2093
P2860
P356
P1476
Once daily versus conventional ...... sults from a randomized trial.
@en
P2093
Peter Jacques
Sunanda Kane
Todd Miodek
William Holderman
P2860
P304
P356
10.2147/PPA.S3698
P407
P577
2008-02-02T00:00:00Z